Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act

HR 3105 Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act2021 - This bill removes federal restrictions on, and creates new protections for, marijuana-related conduct and activities that are authorized by state or tribal law.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of, White House Office

As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $65,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

As the federal government considers how to reconcile state legal cannabis programs with the federal illegality of cannabis, NCR supported legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses.HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals in the 117th Congress. NCR also discussed the potential of the HOPE Act being included in the end-of-year omnibus, which did not ultimately happen. NCR also noted the introduction of the PREPARE Act in the Senate (S.5166) and supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 438: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021. This bill would exempt cigars from FDA regulatory authority. Monitor. S 1183: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. S 2043: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S2974: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR 365: Marijuana 1-to-3 Act of 2021. This bill would reschedule marijuana from schedule I to schedule III. Monitor. HR 1017: This bill would decriminalize and deschedule cannabis. Monitor. HR 2588: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. HR 3051: Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2021. This bill would establish a tobacco product standard prohibiting e-liquids with high levels of nicotine. Monitor. HR 3105: Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. This proposed bill would remove marijuana would from the Controlled Substances Act and allow states to enact legalization. Monitor. HR 3212: This bill would provide that an individual who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. HR 3617: Marijuana Opportunity Reinvestment and Expungement Act. This bill would decriminalize cannabis and study the impact of state legalization of recreational cannabis on the workplace, among other things. Monitor. HR 3883: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. HR5546: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR6286: Clarifying Authority over Nicotine Act of 2021 This bill would give the FDA regulatory authority over tobacco products containing nicotine not derived from tobacco. Monitor. HR 8202: "Preventing Vape Use Act. This bill would recall vaping products that have not been subject to pre-market review. Monitor.

Client expense: Not reported · Firm income: Not reported

Support for the ability of the states to regulate alcohol effectively as outlined in the 21st Amendment to the U.S. Constitution. Issues related to federal oversight of marijuana regulation. H.R. 3617, the MORE Act. H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. S. 4591, The Cannabis Administration and Opportunity Act.

Client expense: $220,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

Monitor pending legislation on cannabis reform, including H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act, H.R.2916, VA Medicinal Cannabis Research Act of 2021, H.R.5977 States Reform Act, S. 4591, Cannabis Adminstration and Opportunity Act, and P.L.117-215, the Medical Marijuana and Cannabidiol Research Expansion Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $8,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the HOPE Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also discussed HOPE's inclusion in year end omni. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supported the Medical Marijuana and Cannabidiol Research Act(signed into law)(HR 8454) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $65,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities. H.R. 8585/S. 4851, the National Plan to End Parkinson's Act - to require the U.S. Department of Health and Human Services (HHS) to carry out a project to prevent and cure Parkinson's disease. Among other components of the project, HHS must (1) implement and periodically update a national plan to coordinate and guide efforts to prevent and cure the disease; (2) improve diagnosis, treatment, and care of those with the disease; and (3) address health and other disparities related to the disease. HHS must also conduct annual assessments on the preparation for and response to the increased burden of Parkinson's disease. In addition, the bill establishes a council, comprised of federal and nonfederal stakeholders, to advise HHS on and make recommendations concerning the prevention and cure of Parkinson's disease. Establishing Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and to allow researchers to gather more data to study the progression of Parkinson's among people living with the disease. Expanding access to health care for people living with Parkinson's via telehealth by removing Medicare telehealth geographic and originating site restrictions, extending coverage and reimbursement for health care providers who bill Medicare for providing services via telehealth (including seeing new patients and audio-only telehealth for clinically appropriate services/visits), ensuring payment parity for telehealth and in-person services, and removing Medicare in-person requirements for accessing mental health services via telehealth. H.R. 2617, the Consolidated Appropriations Act, 2023 Establishing separate Medicare payment requirements for diagnostic radiopharmaceuticals, including DaTscans, so health care providers are adequately reimbursed for furnishing diagnostic tests to help validate patients Parkinsons diagnoses. S. 2609/H.R. 4479, Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 S. 464/H.R. 2163, the Safe Step Act - to amend the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol to enable people living with Parkinsons disease to access the medications they need to best manage their disease S.4906 Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253/H.R.8454, the Cannabidiol and Marihuana Research Expansion Act/ Medical Marijuana and Cannabidiol Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN (Bringing Regulatory Advances Into Neuroscience) Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT (Diverse and Equitable Participation in Clinical Trials) Act S. 331, ABLE (Achieving a Better Life Experience) Age Adjustment Act

Client expense: $20,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying in support of cannabis reform legislation including H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act of 2021 (MORE act), and H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act, and the Cannabis Administration and Opportunity Act, a legislative discussion draft sponsored by Senators Schumer, Wyden, and Booker

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 438: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021. This bill would exempt cigars from FDA regulatory authority. Monitor. S 1183: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. S 2043: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S2974: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR 365: Marijuana 1-to-3 Act of 2021. This bill would reschedule marijuana from schedule I to schedule III. Monitor. HR 1017: This bill would decriminalize and deschedule cannabis. Monitor. HR 2588: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. HR 3051: Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2021. This bill would establish a tobacco product standard prohibiting e-liquids with high levels of nicotine. Monitor. HR 3105: Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. This proposed bill would remove marijuana would from the Controlled Substances Act and allow states to enact legalization. Monitor. HR 3212: This bill would provide that an individual who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. HR 3617: Marijuana Opportunity Reinvestment and Expungement Act. This bill would decriminalize cannabis and study the impact of state legalization of recreational cannabis on the workplace, among other things. Monitor. HR 3883: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. HR5546: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR6286: Clarifying Authority over Nicotine Act of 2021 This bill would give the FDA regulatory authority over tobacco products containing nicotine not derived from tobacco. Monitor. HR 8202: "Preventing Vape Use Act. This bill would recall vaping products that have not been subject to pre-market review. Monitor.

Client expense: Not reported · Firm income: Not reported

Lobbying in support of cannabis reform legislation including H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act of 2021 (MORE act), and H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act, and the Cannabis Administration and Opportunity Act, a legislative discussion draft sponsored by Senators Schumer, Wyden, and Booker

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitor pending legislation on cannabis reform, including H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act, H.R.2916, VA Medicinal Cannabis Research Act of 2021, H.R.5977 States Reform Act, and S. 4591, Cannabis Administration and Opportunity Act.

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for the ability of the states to regulate alcohol effectively as outlined in the 21st Amendment to the U.S. Constitution. Issues related to federal oversight of marijuana regulation. H.R. 3617, the MORE Act. H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. Issues related to the Cannabis Administration and Opportunity Act discussion draft.

Client expense: $150,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

H.R.3105 - Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. To note, NCR submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA S4591) introduced by Senators Schumer, Booker and Wyden last year. NCR supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supports the Cannabidiol and Marihuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $65,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $8,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19, including extension of health care subsidies Advocating for proposed repeal of Department of Health and Human Services rule entitled Securing Updated and Necessary Statutory Evaluations Timely Advocating on for more specific Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and allow researchers to have data to study the disease progression Advocating for expanding access to care via telehealth S.4906 Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253/H.R.8454, the Cannabidiol and Marihuana Research Expansion Act/ Medical Marijuana and Cannabidiol Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act S. 464/H.R. 2163, the Safe Step Act H.R. 3013, the COVID Vaccine Transportation Access Act H.R. 2503, the Social Determinants Accelerator Act of 2021 H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT Act S.Res. 577, A resolution designating April 2022 as "Parkinson's Awareness Month" S. 331, ABLE Age Adjustment Act H.R. 5376, the Inflation Reduction Act of 2022 H.R. 8585/S. 4851, the National Plan to End Parkinson's Act

Client expense: $31,190 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 438: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021. This bill would exempt cigars from FDA regulatory authority. Monitor. S 1183: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. S 2043: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S2974: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR 365: Marijuana 1-to-3 Act of 2021. This bill would reschedule marijuana from schedule I to schedule III. Monitor. HR 1017: This bill would decriminalize and deschedule cannabis. Monitor. HR 2588: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. HR 3051: Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2021. This bill would establish a tobacco product standard prohibiting e-liquids with high levels of nicotine. Monitor. HR 3105: Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. This proposed bill would remove marijuana would from the Controlled Substances Act and allow states to enact legalization. Monitor. HR 3212: This bill would provide that an individual who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. HR 3617: Marijuana Opportunity Reinvestment and Expungement Act. This bill would decriminalize cannabis and study the impact of state legalization of recreational cannabis on the workplace, among other things. Monitor. HR 3684: Infrastructure Investment and Jobs Act. This bill would prohibit e-cigarette use on Amtrak. Monitor. Enacted. HR 3883: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. HR5546: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR6286: Clarifying Authority over Nicotine Act of 2021 This bill would give the FDA regulatory authority over tobacco products containing nicotine not derived from tobacco. Monitor. HR 8202: "Preventing Vape Use Act. This bill would recall vaping products that have not been subject to FDA premarket review. Monitor.

Client expense: Not reported · Firm income: Not reported

Lobbying in support of cannabis reform legislation including H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act of 2021 (MORE act), and H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act, and the Cannabis Administration and Opportunity Act, a legislative discussion draft sponsored by Senators Schumer, Wyden, and Booker

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3105 - Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitor pending legislation on cannabis reform, including H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act, H.R.2916, VA Medicinal Cannabis Research Act of 2021, and H.R.5977 States Reform Act.

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for the ability of the states to regulate alcohol effectively as outlined in the 21st Amendment to the U.S. Constitution. Issues related to federal oversight of marijuana regulation. H.R. 3617, the MORE Act. H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. Issues related to the Cannabis Administration and Opportunity Act discussion draft.

Client expense: $600,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. To note, NCR submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. NCR supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. NCR also supported the PREPARE Act (H.R. 7513) Finally, NCR supports the Cannabidiol and Marihuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $65,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $8,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19, including extension of health care subsidies Advocating for proposed repeal of Department of Health and Human Services rule entitled Securing Updated and Necessary Statutory Evaluations Timely Advocating on for more specific Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and allow researchers to have data to study the disease progression Advocating for expanding access to care via telehealth Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253, the Cannabidiol and Marihuana Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act S. 464/H.R. 2163, the Safe Step Act H.R. 3013, the COVID Vaccine Transportation Access Act H.R. 2503, the Social Determinants Accelerator Act of 2021 H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT Act S.Res. 577: A resolution designating April 2022 as "Parkinson's Awareness Month" S. 331: ABLE Age Adjustment Act

Client expense: $61,153 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act (H.R. 8200); the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 438: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021. This bill would exempt cigars from FDA regulatory authority. Monitor. S 1183: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. S 2043: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S2974: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR 365: Marijuana 1-to-3 Act of 2021. This bill would reschedule marijuana from schedule I to schedule III. Monitor. HR 1017: This bill would decriminalize and deschedule cannabis. Monitor. HR 2588: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. HR 3051: Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2021. This bill would establish a tobacco product standard prohibiting e-liquids with high levels of nicotine. Monitor. HR 3105: Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. This proposed bill would remove marijuana would from the Controlled Substances Act and allow states to enact legalization. Monitor. HR 3212: This bill would provide that an individual who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. HR 3617: Marijuana Opportunity Reinvestment and Expungement Act. This bill would decriminalize cannabis and study the impact of state legalization of recreational cannabis on the workplace, among other things. Monitor. HR 3684: Infrastructure Investment and Jobs Act. This bill would prohibit e-cigarette use on Amtrak. Monitor. Enacted. HR 3883: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. HR5546: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR6286: Clarifying Authority over Nicotine Act of 2021 This bill would give the FDA regulatory authority over tobacco products containing nicotine not derived from tobacco. Monitor.

Client expense: Not reported · Firm income: Not reported

H.R.3105 - Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for the ability of the states to regulate alcohol effectively as outlined in the 21st Amendment to the U.S. Constitution. Issues related to federal oversight of marijuana regulation. H.R. 3617, the MORE Act. H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. Issues related to the Cannabis Administration and Opportunity Act discussion draft.

Client expense: $280,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

H.R. 1996, Secure and Fair Enforcement Banking Act H.R. 3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act H.R. 3617, Marijuana Opportunity, Reinvestment and Expungement (MORE) Act H.R. 5977, the States Reform Act S. ___, the Cannabis Administration and Opportunity Act (DRAFT BILL; Schumer) Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis

Client expense: $720,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1996, Secure and Fair Enforcement Banking Act H.R. 3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act H.R. 3617, Marijuana Opportunity, Reinvestment and Expungement (MORE) Act H.R. 5977, the States Reform Act S. ___, the Cannabis Administration and Opportunity Act (DRAFT BILL; Schumer) Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis

Client expense: $720,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitor pending legislation on cannabis reform, including H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and medical professionals Act, H.R.2916, VA Medicinal Cannabis Research Act of 2021, and State Reform Act.

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which NCR has supported to achieve these goals. To note, NCR submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. NCR supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, NCR noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. Finally, NCR supports the Cannabidiol and Marihuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).

Client expense: Not reported · Firm income: $65,500

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19, including extension of health care subsidies Advocating for proposed repeal of Department of Health and Human Services rule entitled Securing Updated and Necessary Statutory Evaluations Timely Advocating on for more specific Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and allow researchers to have data to study the disease progression Advocating for expanding access to care via telehealth Advocating for rulemaking to ensure standards in the Americans with Disabilities Act (ADA) are applied to the internet Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253, the Cannabidiol and Marihuana Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act S. 464/H.R. 2163, the Safe Step Act H.R. 3013, the COVID Vaccine Transportation Access Act H.R. 2503, the Social Determinants Accelerator Act of 2021 H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT Act S.Res. 577: A resolution designating April 2022 as "Parkinson's Awareness Month"

Client expense: $57,949 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use, including the Secure and Fair Enforcement (SAFE) Banking Act; the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act (H.R. 3105); and the States Reform Act (H.R. 5977).

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying in support of cannabis reform legislation including H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act of 2021 (MORE act), and H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act, and the Cannabis Administration and Opportunity Act, a legislative discussion draft sponsored by Senators Schumer, Wyden, and Booker

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 438: Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021. This bill would exempt cigars from FDA regulatory authority. Monitor. S 1183: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. S 2043: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S2974: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR 365: Marijuana 1-to-3 Act of 2021. This bill would reschedule marijuana from schedule I to schedule III. Monitor. HR 2588: Veterans Medical Marijuana Safe Harbor Act. This bill would permit veterans to use medical marijuana according to state law. Monitor. HR 3051: Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2021. This bill would establish a tobacco product standard prohibiting e-liquids with high levels of nicotine. Monitor. HR 3105: Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. This proposed bill would remove marijuana would from the Controlled Substances Act and allow states to enact legalization. Monitor. HR 3212: This bill would provide that an individual who uses marijuana in compliance with State law may not be denied occupancy of federally assisted housing. Monitor. HR 3617: Marijuana Opportunity Reinvestment and Expungement Act of 2021. This bill would decriminalize and deschedule cannabis. Monitor. HR 3684: Infrastructure Investment and Jobs Act. This bill would prohibit e-cigarette use on Amtrak. Monitor. Enacted. HR 3883: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. HR5546: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act. This bill would fund tobacco control research and prevention for teens. Monitor. HR6286: Clarifying Authority over Nicotine Act of 2021 This bill would give the FDA regulatory authority over tobacco products containing nicotine not derived from tobacco. Monitor.

Client expense: Not reported · Firm income: Not reported

H.R. 1996, Secure and Fair Enforcement Banking Act H.R. 3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act H.R. 3617, Marijuana Opportunity, Reinvestment and Expungement (MORE) Act H.R. 5977, the States Reform Act S. ___, the Cannabis Administration and Opportunity Act (DRAFT BILL; Schumer) Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis

Client expense: $750,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

H.R. 1996, Secure and Fair Enforcement Banking Act H.R. 3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act H.R. 3617, Marijuana Opportunity, Reinvestment and Expungement (MORE) Act H.R. 5977, the States Reform Act S. ___, the Cannabis Administration and Opportunity Act (DRAFT BILL; Schumer) Issues related to the legalization and regulation of cannabidiol (CBD) Issues related to the legalization and regulation of cannabis

Client expense: $750,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

Monitor pending legislation on cannabis reform, including H.R.3105, Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act, H.R.2916, VA Medicinal Cannabis Research Act of 2021, and State Reform Act.

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE